Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
Pedro Henrique Las Casas, Professor at Sorbonne University, Professor of Internal Medicine at Federal University of Minas Gerais (UFMG), Hematologist at Grupo Oncoclínicas, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cancers, adding:
“Happy to share our latest publication in Cancers with Grigoris Gerotziafas.
‘Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin‘
In this study, we explored how anticoagulant agents and quercetin influence cancer cell procoagulant activity, thrombin generation, and endothelial dysfunction induced by cancer-derived extracellular vesicles.
Our findings provide new insights into the complex interactions between cancer, thrombosis, and the vascular microenvironment.
I am grateful to my colleagues and collaborators for their valuable contributions, and especially proud to be part of the Cancer–Angiogenesis–Thrombosis and Hemostasis (CaVITE) research team at the CRSA PARIS, Inserm Paris UMR_S_938, Sorbonne Université.
Many thanks to all co-authors and collaborators who made this work possible.”
Title: Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin
Authors: Mohammed A. Baghdadi, Pedro Henrique Fernandes do Carmo Las Casas, Elisabeth Mbemba, Aurélie Rousseau, Prakasha Kempaiah, Andrey A. Svistunov, Victoria Bitsadze, Michèle Sabbah, Jawed Fareed, Patrick Van Dreden, Varvara Trachana, Eleftheria Lefkou, Grigoris Gerotziafas
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 21, 2026, 07:55A New Era of Precision Imaging for Venous Thromboembolism – JTH
-
Jul 21, 2026, 07:43How to Monitor and Manage Unfractionated Heparin in Practice – JTH
-
Jul 21, 2026, 07:23Arthur Allen: Advancing Outpatient Antithrombotic Stewardship Through ADAPT
-
Jul 21, 2026, 03:19Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
-
Jul 21, 2026, 03:09Francesca Palandri: New Insights Into Anemia Management in Myelofibrosis
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026